Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.78% |
| 2 | Healthcare | 3.27% |
| 3 | Industrials | 2.02% |
| 4 | Financials | 2.02% |
| 5 | Consumer Discretionary | 1.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5676
PUT
Cognex
CGNX
$11.2B
| $1.63M | ﹤0.01% |
20,300
+7,200
| +55% | +$523K |
|
5677
Customers Bancorp
CUBI
$2.77B
| $1.63M | ﹤0.01% |
89,666
+48,618
| +118% | +$771K |
|
5678
CALL
Diodes
DIOD
$4.95B
| $1.63M | ﹤0.01% |
23,100
-21,100
| -48% | -$1.36M |
|
|
CSA
5679
DELISTED
VictoryShares US Small Cap Volatility Wtd ETF
CSA
| $1.63M | ﹤0.01% |
30,201
+516
| +2% | +$24.7K |
|
5680
CALL
Cohu
COHU
$2.96B
| $1.63M | ﹤0.01% |
42,600
+19,300
| +83% | +$527K |
|
5681
PUT
Western Union
WU
$2.24B
| $1.63M | ﹤0.01% |
74,100
-117,600
| -61% | -$2.55M |
|
5682
Acushnet Holdings
GOLF
$5.3B
| $1.62M | ﹤0.01% |
40,044
+24,392
| +156% | +$912K |
|
5683
Midland States Bancorp
MSBI
$691M
| $1.62M | ﹤0.01% |
90,825
-22,363
| -20% | -$365K |
|
5684
VictoryShares US Small Cap High Div Volatility Wtd ETF
CSB
$265M
| $1.62M | ﹤0.01% |
+32,492
| New | +$1.44M |
|
5685
Invesco Large Cap Growth ETF
PWB
$2.5B
| $1.62M | ﹤0.01% |
24,005
+14,964
| +166% | +$965K |
|
5686
New Jersey Resources
NJR
$5.58B
| $1.62M | ﹤0.01% |
45,585
-67,275
| -60% | -$2.19M |
|
5687
CALL
State Street SPDR S&P Dividend ETF
SDY
$21.9B
| $1.62M | ﹤0.01% |
15,300
-21,000
| -58% | -$2.12M |
|
5688
iShares MSCI Thailand ETF
THD
$358M
| $1.62M | ﹤0.01% |
21,032
+8,374
| +66% | +$593K |
|
|
TIGR
5689
PUT
UP Fintech Holding
TIGR
$865M
| $1.62M | ﹤0.01% |
204,200
+136,600
| +202% | +$757K |
|
|
BSJP
5690
DELISTED
Invesco BulletShares 2025 High Yield Corporate Bond ETF
BSJP
| $1.62M | ﹤0.01% |
66,077
-44,872
| -40% | -$1.08M |
|
5691
CALL
Manhattan Associates
MANH
$11.5B
| $1.62M | ﹤0.01% |
15,400
+4,900
| +47% | +$482K |
|
5692
CALL
Vir Biotechnology
VIR
$1.59B
| $1.62M | ﹤0.01% |
60,500
+37,800
| +167% | +$1.23M |
|
|
GNMK
5693
DELISTED
GenMark Diagnostics, Inc
GNMK
| $1.62M | ﹤0.01% |
110,957
-293,343
| -73% | -$3.89M |
|
|
HOLX
5694
PUT
DELISTED
Hologic
HOLX
| $1.62M | ﹤0.01% |
22,200
+8,500
| +62% | +$600K |
|
5695
PUT
Jones Lang LaSalle
JLL
$17B
| $1.62M | ﹤0.01% |
10,900
-500
| -4% | -$64.2K |
|
5696
State Street SPDR Bloomberg International Corporate Bond ETF
IBND
$461M
| $1.62M | ﹤0.01% |
42,649
+32,887
| +337% | +$1.21M |
|
|
CTB
5697
PUT
DELISTED
Cooper Tire & Rubber Co.
CTB
| $1.62M | ﹤0.01% |
39,900
+8,300
| +26% | +$317K |
|
|
TRHC
5698
PUT
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $1.61M | ﹤0.01% |
37,700
+16,600
| +79% | +$630K |
|
5699
PUT
Perion Network
PERI
$381M
| $1.61M | ﹤0.01% |
126,800
+90,300
| +247% | +$798K |
|
|
CLVS
5700
CALL
DELISTED
Clovis Oncology, Inc.
CLVS
| $1.61M | ﹤0.01% |
336,300
-154,500
| -31% | -$781K |
|
Similar funds
Ken Griffin's Q4 2020 Portfolio in Review
As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.
- Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Ken Griffin opened 1,988 new positions and closed 1,130 in Q4 2020.
- Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.